Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MMED · against 205 other Healthcare companies of similar size
Ranked #86 of 206 · scores higher than 58% of peers
Bars: peers in each 10-point band of the growth score20 peers with a growth score of 60–69, including MMED · Click a bar to see the companies
Mainly thanks to its revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.
| Metric | MMED | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 205 reported | 14.3% | 10.0% | 62% | 33% | |
| Earnings per share growthHigher is better · 132 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 198 reported | 11.4% | 9.4% | 57% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 2.8B USD | 99 | 51 | |
| 5 | 37.3B HKD (≈$4.8B) | 98 | 90 | |
| 84 | 32.6B HKD (≈$4.2B) | 68 | 60 | |
| 85 | 21.5B DKK (≈$3.2B) | 67 | 58 | |
| 86 | 43.1B CNY (≈$6.0B) | 66 | 72 | |
| 86 | 414.8B INR (≈$5.0B) | 66 | 73 | |
| 86 | 5.3B USD | 66 | 50 | |
| 89 | 2.9B USD | 65 | 44 | |
| 89 | 9.3B USD | 65 | 29 | |
| 91 | 4.0B USD | 64 | 46 | |
| 92 | 19.0B CNY (≈$2.7B) | 63 | 55 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score